Trails Edge Capital Partners, LP - 31 Dec 2025 SCHEDULE 13G/A Report for X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (XFOR)

Filing Manager
Trails Edge Capital Partners, LP
Reporting Manager
Trails Edge Capital Partners, LP
Security
X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol
XFOR
Shares outstanding
90,124,517 shares
Disclosed Ownership
5,227,222 shares
Ownership
5.8%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:30:12 UTC
Date of event
31 Dec 2025
Previous filing
18 Aug 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Trails Edge Capital Partners, LP 5.8% 5,227,222 5,227,222 0 By: Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC
Trails Edge Biotechnology Master Fund, LP 5.8% 5,227,222 5,227,222 0 By: Trails Edge GP, LLC, GP of Trails Edge Biotechnology Fund GP, LP, GP of Trails Edge Biotechnology Master Fund, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge GP, LLC
Ortav Yehudai 5.8% 5,227,222 5,227,222 0 /s/ Ortav Yehudai Ortav Yehudai / Individual